Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection

Gastroenterology

Volumn 123, Issue 6, 2002, Pages 1793-1803

  Hwang, Il Ran ^a   Kodama, Tadashi ^b   Kikuchi, Shogo ^c   Sakai, Kyoko ^b   Peterson, Leif E ^a   Graham, David Y ^a   Yamaoka, Yoshio ^a,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1BETA;

ADULT; AGED; ALLELE; ARTICLE; ATROPHY; CARCINOGENESIS; CELL INFILTRATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GASTRITIS; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH ANTRUM; STOMACH MUCOSA; TANDEM REPEAT;

HELICOBACTER PYLORI;

EID: 0036893170     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.37043     Document Type: Article

References (48)

1. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model. Gastroenterology 1997;113:1983-1991.
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
3. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96(suppl):615-625.
4. Lee A, Dixon MF, Danon SJ, Kuipers E, Megraud F, Larsson H, Mellgard B. Local acid production and Helicobacter pylori: A unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995;7:461-465.
5. McColl KE, El-Omar E, Gillen D. Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am 2000;29:687703.
6. Sipponen P, Stolte M. Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 1997;29:671-678.
7. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Denventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994;29:425-429.
8. Yamaoka Y, Kita M, Kodama Y, Sawai N, Imanishi J. Helicobacter pylori cag A gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996;110:1744-1752.
9. Wallace JL, Cucala M, Mugridge K, Parente L. Secretagoguespecific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991;261:G559-G564.
10. Wolfe MM, Nompleggi DJ. Cytokine inhibition of gastric acid secretion-a little goes a long way. Gastroenterology 1992;102:2177-2178.
11. Graham DY, Gutierrez O, Gomez M, Yamaoka Y, El-Zimaity HMT. Interleukin (IL)-1 is the likely mediator of reduced acid secretion associated with corpus gastritis (abstr). Gut 2000;47:A38.
12. El-Omar EM, Carrington M, Chow W-H, McColl KEL, Bream JH, Young HA, Herrera J, Lissowska J, Yuan C-C, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402 (correction published in Nature 2001;412:99).
13. Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001;48:765-773.
14. Di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at -511 in the human interleukin-1β gene. Hum Mol Genet 1992;1:450.
15. Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 1998;43:33-39.
16. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW. Polymorphism in human IL-1 receptor antagnoist gene intron 2 is caused by variable numbers of an 86-base pair tandem repeat. Hum Genet 1993;91:403-404.
17. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1β genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001;36:696-699.
18. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simoes M. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001;121:823-829.
19. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimurra H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology. 2002;123:92-105.
20. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taql polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
21. Santtila S, Savinainen K, Hurme M. Presence of the IL-1 RA allele 2(IL1RN*2) is associated with enhanced IL-1 beta production in vitro. Scand J Immunol 1998;47:195-198.
22. Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, Davidson RN, Toossi Z. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis. J Exp Med 1999;189:1863-1873.
23. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human moncytes inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995;99:303-310.
24. Andus T, Daig R, Vogl D, Aschenbrenner E, Lock G, Hollerbach S, Kollinger M, Scholmerich J, Gross V. Imbalance of the interleukin 1 system in colonic mucosa-association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2. Gut 1997;41:651-657.
25. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma level are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998;28:2598-2602.
26. Tountas NA, Casini-Raggi V, Yang H, Di Giovine FS, Vecchi M, Kam L, Melani L, Pizarro TT, Rotter JI, Cominelli F. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999;117:806-813.
27. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, Imanishi J. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 1998;42:609-617.
28. El-Zimaity HM, Graham DY, Al-Assi MT, Malaty H, Karttunen TJ, Graham DP, Huberman RM, Genta RM. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996;27:35-41.
29. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between clinical presentation, Helicobacter pylori density, interleukin 1β and 8 production, and cagA status. Gut 1999;45:804-811.
30. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 1998;4:241-253.
31. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobater pylori iceA, cagA, and vacA status and clinical outcome: Studies in four different countries. J Clin Microbiol 1999;37:2274-2279.
32. Zheng C, Huang D, Bergenbrant S, Sundblad A, Osterborg A, Bjorkholm M, Holm G, Yi Q. Interleukin 6, tumor necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Hematol 2000;109:39-45.
33. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M. Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000;47:571-574.
34. Guasch JF, Bertina RM, Reitsma P. Five novel intragenic dimorphism in the human interleukin-1 genes combine to high informativity. Cytokine 1996;8:598-602.
35. Lewis PO, Zaykin D. Genetic Data Analysis: Computer Program for the Analysis of Allelic Data. Version 1.0 (d16c). Available at: Http://lewis.eeb.uconn.edu/lewishome/software.html. Accessed February 23, 2002.
36. Hamajima N, Matsuo K, Saito T, Tajima K, Okuma K, Yamao K, Tominaga S. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 2001;92:383-389.
37. Hulkkonen J, Laippala P, Hurme M. A rare allele combiation of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur Cytokine Netw 2000;11:251-255.
38. Hurme M, Labenpobia N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune disease. Ann Med 1998;30:469-473.
39. Tseng LH, Chen PJ, Lin MT, Shau WY, Chaung SM, Martin PJ, Hansen JA. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: Further definition of the IL-1β and IL-1Ra polymorphism in North American Caucasians and Taiwanese Chinese. Tissue Antigens 2001;57:318-324.
40. Suzuki H, Matsui Y, Kashiwagi H. Interleukin-1 receptor antagonist gene polymorphims in Japanese patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:389-390.
41. Shu KH, Lee SH, Cheng Ch, Wu MJ, Lian JD. Impact of inteleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphism on IgA nephropathy. Kidney Int 2000;58:783-789.
42. Cox A, Camp NJ, Nicklin MJ, di Giovine FS, Duff GW. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 1998;62:1180-1188.
43. Kekki M, Samloff IM, Ihamaki T, Varis K, Siurala M. Age- and sex-related behavior of gastric acid secretion at the population level. Scand J Gastroenterol 1982;17:737-743.
44. Kimura K. Chronological transition of the fundic-pylori border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972;63:584-592.
45. Sipponen P. Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol 2001;32:196-202.
46. Lambert R. Chronic gastritis (general review). Digestion 1972;7:83-126.
47. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19(suppl 1):S37-43.
48. Graham DY, Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: The unfulfilled promise. Helicobacter 2000;5(suppl 1):S3-S9.